347 related articles for article (PubMed ID: 19763820)
1. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.
Beck BH; Kim HG; Kim H; Samuel S; Liu Z; Shrestha R; Haines H; Zinn K; Lopez RD
Breast Cancer Res Treat; 2010 Jul; 122(1):135-44. PubMed ID: 19763820
[TBL] [Abstract][Full Text] [Related]
2. Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer.
Liu Z; Eltoum IE; Guo B; Beck BH; Cloud GA; Lopez RD
J Immunol; 2008 May; 180(9):6044-53. PubMed ID: 18424725
[TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.
Kang N; Zhou J; Zhang T; Wang L; Lu F; Cui Y; Cui L; He W
Cancer Biol Ther; 2009 Aug; 8(16):1540-9. PubMed ID: 19471115
[TBL] [Abstract][Full Text] [Related]
4. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
Kabelitz D; Wesch D; Pitters E; Zöller M
J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
Chen J; Niu H; He W; Ba D
Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
[TBL] [Abstract][Full Text] [Related]
7. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells.
Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D
Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235
[TBL] [Abstract][Full Text] [Related]
8. CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.
Zhao H; Xi X; Cui L; He W
Cell Mol Immunol; 2012 Mar; 9(2):147-54. PubMed ID: 21909128
[TBL] [Abstract][Full Text] [Related]
9. The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.
Pereboeva L; Harkins L; Wong S; Lamb LS
Cancer Immunol Immunother; 2015 May; 64(5):551-62. PubMed ID: 25676710
[TBL] [Abstract][Full Text] [Related]
10. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
Liu Z; Guo B; Lopez RD
J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
[TBL] [Abstract][Full Text] [Related]
11. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
Zhou J; Kang N; Cui L; Ba D; He W
Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
[TBL] [Abstract][Full Text] [Related]
12. Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
Hoeres T; Smetak M; Pretscher D; Wilhelm M
Front Immunol; 2018; 9():800. PubMed ID: 29725332
[TBL] [Abstract][Full Text] [Related]
13. Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
Liu Z; Noh HS; Chen J; Kim JH; Falo LD; You Z
J Immunol; 2008 Sep; 181(6):4363-70. PubMed ID: 18768895
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
[TBL] [Abstract][Full Text] [Related]
15. Murine T cell determination of pregnancy outcome: I. Effects of strain, alphabeta T cell receptor, gammadelta T cell receptor, and gammadelta T cell subsets.
Arck PC; Ferrick DA; Steele-Norwood D; Croitoru K; Clark DA
Am J Reprod Immunol; 1997 Jun; 37(6):492-502. PubMed ID: 9228307
[TBL] [Abstract][Full Text] [Related]
16. Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.
Jensen SM; Meijer SL; Kurt RA; Urba WJ; Hu HM; Fox BA
J Immunol; 2003 Feb; 170(4):2014-21. PubMed ID: 12574371
[TBL] [Abstract][Full Text] [Related]
17. IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo.
Cha E; Graham L; Manjili MH; Bear HD
Breast Cancer Res Treat; 2010 Jul; 122(2):359-69. PubMed ID: 19826947
[TBL] [Abstract][Full Text] [Related]
18. Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
Santolaria T; Robard M; Léger A; Catros V; Bonneville M; Scotet E
J Immunol; 2013 Aug; 191(4):1993-2000. PubMed ID: 23836057
[TBL] [Abstract][Full Text] [Related]
19. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy.
Wang LX; Kjaergaard J; Cohen PA; Shu S; Plautz GE
J Immunol; 2004 Mar; 172(6):3462-8. PubMed ID: 15004146
[TBL] [Abstract][Full Text] [Related]
20. γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.
Janssen A; Villacorta Hidalgo J; Beringer DX; van Dooremalen S; Fernando F; van Diest E; Terrizi AR; Bronsert P; Kock S; Schmitt-Gräff A; Werner M; Heise K; Follo M; Straetemans T; Sebestyen Z; Chudakov DM; Kasatskaya SA; Frenkel FE; Ravens S; Spierings E; Prinz I; Küppers R; Malkovsky M; Fisch P; Kuball J
Cancer Immunol Res; 2020 Apr; 8(4):530-543. PubMed ID: 32019779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]